Blair William & CO Repligen Corp Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Repligen Corp stock. As of the latest transaction made, Blair William & CO holds 2,085 shares of RGEN stock, worth $334,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,085

Previous 2,768 24.67%

Holding current value

$334,663

Previous $348,000 10.92%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $81,816 - $114,300	-683 Reduced 24.67%	2,085 $310,000
Q2 2024 Aug 12, 2024	SELL	$120.0 - $182.95 $2.71 Million - $4.13 Million	-22,567 Reduced 89.07%	2,768 $348,000
Q1 2024 May 09, 2024	SELL	$170.78 - $208.42 $345,658 - $421,842	-2,024 Reduced 7.4%	25,335 $4.66 Million
Q4 2023 Feb 12, 2024	SELL	$114.17 - $185.35 $193,632 - $314,353	-1,696 Reduced 5.84%	27,359 $4.92 Million
Q3 2023 Nov 09, 2023	SELL	$138.78 - $176.51 $2.14 Million - $2.72 Million	-15,413 Reduced 34.66%	29,055 $4.62 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $166,796 - $217,273	1,205 Added 2.79%	44,468 $6.29 Million
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $35,634 - $45,761	-231 Reduced 0.53%	43,263 $7.28 Million
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $666,409 - $904,957	4,103 Added 10.42%	43,494 $7.36 Million
Q3 2022 Nov 09, 2022	BUY	$160.42 - $256.21 $690,768 - $1.1 Million	4,306 Added 12.27%	39,391 $7.37 Million
Q2 2022 Aug 10, 2022	BUY	$140.68 - $188.02 $4.54 Million - $6.06 Million	32,250 Added 1137.57%	35,085 $5.7 Million
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $77,048 - $123,304	-478 Reduced 14.43%	2,835 $533,000
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $55,707 - $68,505	225 Added 7.29%	3,313 $877,000
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $5,843 - $9,726	-30 Reduced 0.96%	3,088 $892,000
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $166,699 - $222,054	-1,005 Reduced 24.38%	3,118 $622,000
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $487,900 - $612,033	-2,705 Reduced 39.62%	4,123 $802,000
Q4 2020 Feb 09, 2021	SELL	$148.08 - $206.57 $11,550 - $16,112	-78 Reduced 1.13%	6,828 $1.31 Million
Q3 2020 Nov 06, 2020	BUY	$122.51 - $158.27 $92,740 - $119,810	757 Added 12.31%	6,906 $1.02 Million
Q2 2020 Aug 12, 2020	BUY	$94.33 - $140.48 $7,546 - $11,238	80 Added 1.32%	6,149 $760,000
Q1 2020 May 11, 2020	SELL	$84.96 - $109.14 $1.37 Million - $1.76 Million	-16,100 Reduced 72.62%	6,069 $586,000
Q4 2019 Feb 13, 2020	SELL	$73.84 - $93.08 $122,426 - $154,326	-1,658 Reduced 6.96%	22,169 $2.05 Million
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $370,986 - $462,268	-4,840 Reduced 16.88%	23,827 $1.83 Million
Q2 2019 Aug 13, 2019	SELL	$54.2 - $85.95 $294,197 - $466,536	-5,428 Reduced 15.92%	28,667 $2.46 Million
Q1 2019 May 14, 2019	SELL	$49.45 - $62.8 $17,060 - $21,666	-345 Reduced 1.0%	34,095 $2.01 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $117,802 - $168,136	-2,441 Reduced 6.62%	34,440 $1.82 Million
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $49,935 - $62,920	-1,067 Reduced 2.81%	36,881 $2.05 Million
Q2 2018 Aug 13, 2018	SELL	$35.26 - $47.04 $1,868 - $2,493	-53 Reduced 0.14%	37,948 $1.79 Million
Q1 2018 May 15, 2018	SELL	$30.92 - $37.27 $660,203 - $795,789	-21,352 Reduced 35.97%	38,001 $1.38 Million
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $1.13 Million - $1.36 Million	-34,888 Reduced 37.02%	59,353 $2.15 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $3.49 Million - $4.34 Million	94,241	94,241 $3.61 Million

Others Institutions Holding RGEN

# of Institutions

489

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account